Izela Bernal-Sore

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Mifepristone is the only FDA-approved drug for glycaemia control in patients with Cushing's syndrome and type 2 diabetes. Mifepristone also has beneficial effects in animal models of diabetes and patients with antipsychotic treatment-induced obesity. However, the mechanisms through which Mifepristone produces its beneficial effects are not completely(More)
  • 1